Professional Certificate in Immuno-Oncology & Antibody Therapy
-- ViewingNowThe Professional Certificate in Immuno-Oncology & Antibody Therapy is a comprehensive course designed to equip learners with the essential skills needed to excel in the rapidly growing field of cancer immunotherapy. This certificate program emphasizes the importance of harnessing the power of the immune system to fight cancer, making it highly relevant in today's medical landscape where personalized medicine and targeted therapies are on the rise.
7,143+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Fundamentals of Immuno-Oncology: An introduction to the immune system and its interaction with cancer cells; basic principles and mechanisms of immunotherapy.
⢠Antibody Therapy: Overview of monoclonal antibodies, their structure, and function; antibody-based therapeutic strategies in oncology.
⢠Immunotherapy Approaches: Examination of various immunotherapy techniques, including checkpoint inhibitors, cancer vaccines, and adoptive cell transfer.
⢠Clinical Trials & Translational Research: Analysis of the clinical trial process, with a focus on immuno-oncology and antibody therapy; exploration of translational research in the field.
⢠Biological Basis of Immuno-Oncology: Deep dive into the molecular and cellular aspects of the immune system and cancer, highlighting key targets and pathways.
⢠Emerging Therapies in Immuno-Oncology: Overview of novel immunotherapeutic approaches and antibody therapies, including CAR-T cells, bispecific antibodies, and oncolytic viruses.
⢠Tumor Microenvironment & Immunotherapy: Exploration of the tumor microenvironment and its impact on immunotherapy; strategies to modulate the microenvironment for improved therapeutic outcomes.
⢠Diagnostic & Predictive Biomarkers in Immuno-Oncology: Examination of biomarkers used in the diagnosis, prognosis, and prediction of response to immuno-oncology and antibody therapies.
⢠Combination Therapies in Immuno-Oncology: Investigation of combined immunotherapy and antibody therapy strategies to enhance treatment efficacy and overcome resistance.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë